Susquehanna International Group, LLP Sio Gene Therapies Inc. Call Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 14, 2022	SELL	$1.29 - $2.36 $18,963 - $34,692	-14,700 Reduced 50.52%	14,400 $19,000
Q3 2021 Nov 15, 2021	SELL	$1.81 - $2.7 $51,042 - $76,140	-28,200 Reduced 49.21%	29,100 $63,000
Q2 2021 Aug 11, 2021	BUY	$2.07 - $2.89 $57,959 - $80,920	28,000 Added 95.56%	57,300 $156,000
Q1 2021 May 17, 2021	BUY	$2.34 - $3.44 $10,998 - $16,168	4,700 Added 19.11%	29,300 $76,000
Q4 2020 Feb 16, 2021	BUY	$1.91 - $5.63 $46,986 - $138,498	24,600 New	24,600 $68,000

147K

Ticker SIOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,975,200
Description
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.